1. 164 THE UPDATED HOMA MODEL: COMPARISON OF PERFORMANCE AGAINST EUGLYCEMIC AND HYPERGLYCEMIC CLAMPS. (1st January 2005) Authors: Wallace, T. M.; Levy, J. C.; Matthews, D. R. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes. Issue 4 (12th February 2019) Authors: Matthews, D. R.; Paldánius, P. M.; Proot, P.; Foley, J. E.; Stumvoll, M.; Del Prato, S. Journal: Diabetic medicine Issue: Volume 36:Issue 4(2019) Page Start: 505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes. Issue 1 (8th December 2015) Authors: Fulcher, G.; Matthews, D. R.; Perkovic, V.; de Zeeuw, D.; Mahaffey, K. W.; Mathieu, C.; Woo, V.; Wysham, C.; Capuano, G.; Desai, M.; Shaw, W.; Vercruysse, F.; Meininger, G.; Neal, B. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 1(2016) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials. Issue 11 (23rd September 2015) Authors: Karagiannis, T.; Liakos, A.; Bekiari, E.; Athanasiadou, E.; Paschos, P.; Vasilakou, D.; Mainou, M.; Rika, M.; Boura, P.; Matthews, D. R.; Tsapas, A. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 11(2015:Nov.) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glycaemic efficacy of canagliflozin is largely independent of baseline β‐cell function or insulin sensitivity. Issue 12 (15th November 2016) Authors: Matthews, D. R.; Zinman, B.; Tong, C.; Meininger, G.; Polidori, D. Journal: Diabetic medicine Issue: Volume 33:Issue 12(2016:Dec.) Page Start: 1744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2‐year results from the LEAD‐2 study. Issue 3 (11th October 2012) Authors: Nauck, M.; Frid, A.; Hermansen, K.; Thomsen, A. B.; During, M.; Shah, N.; Tankova, T.; Mitha, I.; Matthews, D. R. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 3(2013:Mar.) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prediction of 10‐year vascular risk in patients with diabetes: the AD‐ON risk score. Issue 3 (15th January 2016) Authors: Woodward, M.; Hirakawa, Y.; Kengne, A.‐P.; Matthews, D. R.; Zoungas, S.; Patel, A.; Poulter, N.; Grobbee, R.; Cooper, M.; Jardine, M.; Chalmers, J. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 3(2016) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard‐of‐care metformin monotherapy—the VERIFY trial: a randomized double‐blind trial. Issue 10 (17th July 2014) Authors: Del Prato, S.; Foley, J. E.; Kothny, W.; Kozlovski, P.; Stumvoll, M.; Paldánius, P. M.; Matthews, D. R. Journal: Diabetic medicine Issue: Volume 31:Issue 10(2014:Oct.) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The influence of family history of diabetes on disease prevalence and associated metabolic risk factors among Sri Lankan adults. Issue 3 (27th November 2014) Authors: Katulanda, P.; Ranasinghe, P.; Jayawardena, R.; Sheriff, R.; Matthews, D. R. Journal: Diabetic medicine Issue: Volume 32:Issue 3(2015:Mar.) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. Issue 6838 (23rd May 1992) Authors: Betteridge, D. J.; Bhatnager, D.; Bing, R. F.; Durrington, P. N.; Evans, G. R.; Flax, H.; Jay, R. H.; Lewis-Barned, N.; Mann, J.; Matthews, D. R. Journal: BMJ Issue: Volume 304:Issue 6838(1992) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗